CanaQuest Medical Corp.
CANQFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2121
P/E Ratio—
52W High$0.0193
52W Low$0.0001
CanaQuest Medical Corp. (CANQF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CANQF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Dec 31, 2024EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Dec 31, 2024
After Market Close
CANQF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Sep 30, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2024 | Jun 29, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2024 | Mar 30, 2024 | — | -$0.02 | — | $0.00B | — | — |
| — Q4 FY2023 | Dec 30, 2023 | — | -$0.02 | — | $0.00B | — | — |
| — Q3 FY2023 | Sep 29, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 29, 2023 | — | -$0.00 | — | — | — | — |
| — Q1 FY2023 | Mar 30, 2023 | — | -$0.00 | — | — | — | — |
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Sep 30, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 29, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Mar 30, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 30, 2023
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Sep 29, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 29, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Mar 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2024 | Dec 31, 2024 | — | $0.02 | $0.02 | +0.00% |
| — Q3 FY2024 | Sep 30, 2024 | — | $0.05 | $0.05 | +0.00% |
| — Q2 FY2024 | Jun 29, 2024 | — | $0.08 | $0.08 | +0.13% |
| — Q1 FY2024 | Mar 30, 2024 | — | $0.10 | $0.10 | +0.00% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.24 | $0.33 | +37.50% |
| — Q3 FY2023 | Sep 29, 2023 | — | $0.19 | $0.19 | +0.00% |
| — Q2 FY2023 | Jun 29, 2023 | — | $0.15 | $0.15 | +0.00% |
| — Q1 FY2023 | Mar 30, 2023 | — | $0.18 | $0.18 | +0.00% |
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q3 FY2024+0.00%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q2 FY2024+0.13%
Report Date
Jun 29, 2024
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q1 FY2024+0.00%
Report Date
Mar 30, 2024
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q4 FY2023+37.50%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.33
Q3 FY2023+0.00%
Report Date
Sep 29, 2023
EPS Beat/Miss
—
Price Before
$0.19
Price After
$0.19
Q2 FY2023+0.00%
Report Date
Jun 29, 2023
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q1 FY2023+0.00%
Report Date
Mar 30, 2023
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Beat Rate0 / 8 quarters
Largest Move+37.50% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CANQF ends December
CanaQuest Medical Corp. (CANQF) most recently reported earnings on December 31, 2024 for Q4 FY2024, posting EPS of $-0.00 (in line with the analyst consensus of —). The next CANQF earnings date is expected around September 1, 2026.
Each quarter, investors track CANQF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CANQF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CANQF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CANQF earnings · 4 questionsCanaQuest Medical Corp.'s next earnings report is expected around September 1, 2026. CANQF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CANQF historically reports after market close (AMC).
CANQF earnings datewhen is CANQF earningsCANQF next earnings datewhen does CANQF report earningsCANQF earnings calendar
▸ Source: FMP · CanaQuest Medical Corp. SEC filings · US GAAP · CanaQuest Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026